ClinicalTrials.gg

CSL Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 268 studies whose lead sponsor is CSL Limited or one of 9 companies grouped under it. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.

Our grouping of 10 registry names, not the registry’s. See them and correct one ↓

Compare CSL with Sanofi and Novo Nordisk →

Pipeline: 11 programs

Each counted once: 11 with a study CSL Limited leads registered in the last two years.

  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of CSL Limited’s own registered studies; CSL Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs CSL Limited’s studies test, most open studies first — 37 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 37; every drug is on its own page, and each page lists its sponsors.

Coming up

4 of CSL Limited’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. 1J
  9. J
  10. 1A
  11. S
  12. 1O
  13. N

Add all 4 to your calendar (.ics) → With an account.

All 268 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now187%Recruiting 17 · Enrolling by invitation 1
  • Under way, not recruiting41%
  • Completed20777%
  • Stopped early3212%Terminated 24 · Withdrawn 8
  • Status unknown or other73%Status unknown 6 · Available 1

Phase

Where

  • United States125
  • Germany85
  • United Kingdom63
  • Australia61
  • Poland51
  • Canada49

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 2011
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 626

By the year each study started; 19 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to CSL Limited.

  • CSL Behring
    Acquired — became part of CSL Limited, Mar 31, 2004 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    145 studies →
  • Seqirus
    Acquired — became part of CSL Limited, Jul 31, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    53 studies →
  • Vifor Pharma
    Acquired — became part of CSL Limited, Aug 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies →
  • Vifor (International) Inc.
    Acquired — became part of CSL Limited, Aug 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • CSL Limited
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies
  • Vifor Fresenius Medical Care Renal Pharma
    Acquired — became part of CSL Limited, Aug 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Relypsa, Inc.
    Acquired — became part of CSL Limited, Aug 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • VIFORFRANCE
    Acquired — became part of CSL Limited, Aug 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Vifor Pharma, Inc.
    Acquired — became part of CSL Limited, Aug 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Calimmune, Inc.
    Acquired — became part of CSL Limited, Aug 31, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions CSL Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 268. Browse all 268 →